Logo Image

Shorts

Growing Rates of ICI-Arthritis After Cancer Treatment
0:43
Growing Rates of ICI-Arthritis After Cancer Treatment
10 days ago
by
Jack Arnold, MBBS, MRCP, PhD(+1 more)
Be Proactive in Gout Management
1:11
Be Proactive in Gout Management
15 days ago
by
Jack Arnold, MBBS, MRCP, PhD
ALLEGORY: Expanding Obinutuzmab to SLE
2:05
ALLEGORY: Expanding Obinutuzmab to SLE
3 months ago
by
Maria Dall'Era, MD
Hidden Inequities in Lupus Care and Steroid Use
0:46
Hidden Inequities in Lupus Care and Steroid Use
4 months ago
by
Sarah Dyball, MBBS, PhD(+1 more)
Why Does ICI-Induced Inflammatory Arthritis Persist?
0:39
Why Does ICI-Induced Inflammatory Arthritis Persist?
4 months ago
by
Kate Harnden, MBChB
CAR T's Place in Lupus Treatment
1:01
CAR T's Place in Lupus Treatment
6 months ago
by
Rihards Buss, MD(+2 more)
A Vicious Cycle: Obesity and Autoimmune Disease
0:38
A Vicious Cycle: Obesity and Autoimmune Disease
7 months ago
by
Jack Arnold, MBBS, MRCP, PhD
GLP-1's Benefit for Osteoarthritis
0:44
GLP-1's Benefit for Osteoarthritis
8 months ago
by
Jack Arnold, MBBS, MRCP, PhD
Favorable Benefit-Risk Profile With Osteoporosis Prevention
0:53
Favorable Benefit-Risk Profile With Osteoporosis Prevention
9 months ago
by
Gina Woods, MD
Imaging Advances in Vasculitis
0:33
Imaging Advances in Vasculitis
9 months ago
by
Anisha B. Dua, MD, MPH
Shifting Attention to Difficult-to-Treat PsA and AxSpA
0:51
Shifting Attention to Difficult-to-Treat PsA and AxSpA
9 months ago
by
Eric M. Ruderman, MD
Evolving our Understanding of Lupus
0:45
Evolving our Understanding of Lupus
9 months ago
by
Susan Manzi, MD, MPH
SLE Treatment Choices: Subcutaneous or Intravenous?
0:38
SLE Treatment Choices: Subcutaneous or Intravenous?
9 months ago
by
Susan Manzi, MD, MPH
The Promise of TYK2 Inhibition for PSA
0:43
The Promise of TYK2 Inhibition for PSA
9 months ago
by
Philip J. Mease, MD